Skip to main content
PMC home page
Springer logoLink to Springer
. 2020 Jun 13;47(10):2481. doi: 10.1007/s00259-020-04908-6

Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

E J van Helden 1, S G Elias 2, S L Gerritse 1, S C van Es 3, E Boon 4, M C Huisman 5, N C T van Grieken 6, H Dekker 1, G A M S van Dongen 5, D J Vugts 5, R Boellaard 5, C M L van Herpen 4, E G E de Vries 3, W J G Oyen 7,8, A H Brouwers 9, H M W Verheul 1, O S Hoekstra 5, C W Menke-van der Houven van Oordt 1,2,3,4,5,6,7,8,9,✉
PMCID: PMC7645532  PMID: 32535653

Correction to: European Journal of Nuclear Medicine and Molecular Imaging (2020) 47:849–859.

10.1007/s00259-019-04555-6

The Electronic Supplementary Materials are missing in the original article. Kindly check the Electronic Supplementary Materials in this article.

The Publisher regrets this error.

Electronic supplementary material

ESM 1 (4.8MB, docx)

(DOCX 4.84 mb)

Footnotes

This article is part of the Topical Collection on Erratum

The online version of the original article can be found at 10.1007/s00259-019-04555-6

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ESM 1 (4.8MB, docx)

(DOCX 4.84 mb)

Articles from European Journal of Nuclear Medicine and Molecular Imaging are provided here courtesy of Springer

RESOURCES